In episode 44, the conversation begins with an exploration of current generative AI trends and how they differ from traditional machine learning approaches. The episode highlights the innovative use of generative AI by companies like Pfizer and Takeda to accelerate drug development and clinical trials. It also features success stories from CogniSure and Comcast, focusing on enhancing customer insights and improving call center responses. The discussion continues with CMA CGM and Dick’s Sporting Goods leveraging AI for dynamic pricing and personalized marketing strategies. Insights from McKinsey and Accenture demonstrate how generative AI is streamlining operations. The episode concludes with a wrap-up of these transformative use cases.

(0:00) Welcome and introduction to episode 44

(0:34) Generative AI trends and differentiation from legacy ML

(2:00) Pfizer and Takeda: Accelerating drug development and clinical trials with generative AI

(3:34) CogniSure and Comcast: Enhancing customer insights and call center responses

(4:42) CMA CGM and Dick’s Sporting Goods: Dynamic pricing and personalized marketing

(5:53) McKinsey and Accenture: Streamlining operations with generative AI

(7:18) Conclusion and wrap-up of episode 44